It’s a little fish attacking the big whale, but with a huge legal hammer. If Biogen is telling it’s shareholders that they have something which Cerebain developed and discarded, and are lying about how it was developed, believe me, there’s grounds for a lawsuit. Investors love these types of legal angles.
Market Data 
Markets 
AI
